2007
DOI: 10.1111/j.1600-0609.2007.01010.x
|View full text |Cite
|
Sign up to set email alerts
|

Association between promoter and coding region mutations of UDP‐glucuronosyltransferase 1A1 and β‐thalassemia/Hb E with cholelithiasis

Abstract: This study shows that the combined TATA-box variants and G71R mutations of the UGT1A1 is associated with cholelithiasis in beta-thal/Hb E.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2009
2009
2012
2012

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 33 publications
0
2
0
Order By: Relevance
“…The incidence of thalassemia is very high in some east Asian populations, such as in Thailand, about 40% have thalassemia traits or are carriers (27). The frequency of variation at nucleotide 211, the major variant site within the coding region of the UGT1A1 gene in Asians, is lower in Thailand (17%) than in Taiwanese (23%) (28). Thus, the study of the relationship between bilirubin concentrations and UGT1A1 gene status is more important for Taiwanese thalassemia carriers and Thailand thalassemia carriers than for Japanese thalassemia carriers.…”
Section: Discussionmentioning
confidence: 99%
“…The incidence of thalassemia is very high in some east Asian populations, such as in Thailand, about 40% have thalassemia traits or are carriers (27). The frequency of variation at nucleotide 211, the major variant site within the coding region of the UGT1A1 gene in Asians, is lower in Thailand (17%) than in Taiwanese (23%) (28). Thus, the study of the relationship between bilirubin concentrations and UGT1A1 gene status is more important for Taiwanese thalassemia carriers and Thailand thalassemia carriers than for Japanese thalassemia carriers.…”
Section: Discussionmentioning
confidence: 99%
“…In βthalassemia disease, considerable effort has been put into a search for the "holy grail" of disease modifying genes, particularly quantitative trait locus (QTL) linked to a high propensity for postnatal γ globin gene expression; however, little progress has been made in the search for genetic modifiers in Hb H. Most studies in Hb H disease follow in the footsteps of those in β-thalassemia, such as the role of the HFE polymorphism [25][26][27] and the UGT1 variants on the risk of hyperbilirubinemia and gallstone development. [28][29][30] However, such studies have not shed any light on understanding the complicated genotype-phenotype correlation, particularly in cases with non-deletional Hb H disease. In clinical practice, these studies merely suggest the risk of possible related complications with little clinical application.…”
Section: Genetic Modifiersmentioning
confidence: 99%